Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana

Anselm Komla Abotsi, Ebenezer Inkoom, Eric Ribaira, Rozenn Le Mentec, Pierre Lévy, Herve Lafarge and Alexandra de Sousa
Additional contact information
Anselm Komla Abotsi: Université du Ghana = University of Ghana
Ebenezer Inkoom: Université du Ghana = University of Ghana
Eric Ribaira: UNICEF - WHO
Rozenn Le Mentec: AEDES - AEDES
Pierre Lévy: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres, Legos - Laboratoire d'Economie et de Gestion des Organisations de Santé - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres
Herve Lafarge: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres
Alexandra de Sousa: UNICEF - WHO

Post-Print from HAL

Abstract: Aim: In order to integrate malaria Intermittent Preventive Treatment in infants (IPTi) into the Ghana national immunization programme, there was the need to evaluate the feasibility of IPTi by assessing the intervention operational issues including its implementation costs, and its cost effectiveness. Study Design: Cross-sectional study. Place and Duration of Study: Upper East Region, Ghana, between July 2007 and July 2009 Methods: We calculated the costs of administrating IPTi during vaccination sessions; the costs of programme implementation during the first year of implementation (start-up costs) and in routine years (recurrent costs). For the purposes of cost-effectiveness analysis, all economic costs (including financial and opportunity costs) and the net cost were estimated. To estimate the cost effectiveness ratios of IPTi, the aggregate cost of providing the intervention for a reference target population of 1,000 infants was divided by its health outcome. Sensitivity analyses were carried out to understand the results robustness. Results: IPTi gross costs in start up and in routine years were estimated at 70.66 cents and 29.72 cents per dose, or $2.0 and $0.87 per infant, respectively. The gross cost per DALY saved was estimated at $3.49 and the net cost of IPTi for 1,000 infants was $-3,416.38 in the routine years rending IPTi a highly cost saving intervention. Sensitivity analyses showed that the cost per DALY saved never went up more than $4.50 maintaining the intervention still highly cost effective. Conclusion: IPTi in Ghana is a highly and robust cost effective intervention. The intervention is cost-saving and should be scaled up nationally to save children's health and economic capital.

Keywords: incremental costs; indirect delivery cost; intermittent preventive treatment in infants; health outcome; Malaria; direct delivery cost; economic cost; cost effectiveness analysis (search for similar items in EconPapers)
Date: 2012
Note: View the original document on HAL open archive server: https://hal.science/hal-01293706v1
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in International Journal of Tropical Disease & Health, 2012, 2 (1), pp.1-15. ⟨10.9734/IJTDH/2012/1017⟩

Downloads: (external link)
https://hal.science/hal-01293706v1/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01293706

DOI: 10.9734/IJTDH/2012/1017

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().